Clinical Trial

BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency

Available
View on ClinicalTrials.gov →
Summary
The goal of this program is to provide patients with Limbal Stem Cell Deficiency access to the BRM421 eye drops. Participants will: * Use BRM421 two times a day for at least 12 weeks * Visit the clinic monthly for checkups and tests
Trial Details
NCT Number NCT07422389
Lead Sponsor BRIM Biotechnology Inc.
Collaborators: University of Pennsylvania
Conditions Limbal Stem Cell Deficiency (LSCD)
Updated on ClinicalTrials.gov 2026-02-20